|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||0.0002 - 0.0002|
|52 Week Range||0.0001 - 0.8900|
|Beta (5Y Monthly)||5.11|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 04, 2020 - Apr 08, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for PARNFLearn more
SYDNEY, AUSTRALIA / ACCESSWIRE / July 14, 2021 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, provides notice of its Annual General Meeting to be held Thursday, 5th August 2021 at 8:30 a. (Australian Eastern Standard Time)NOTICE OF ANNUAL GENERAL MEETING AND EXPLANATORY MEMORANDUMNotice is given that the Annual General Meeting of shareholder
DW Healthcare Partners ("DWHP") a healthcare-focused private equity firm, announced the completion of its investment in Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF) ("Parnell" or the "Company"). Founded over 50 years ago in Australia, Parnell is a fully integrated manufacturer and developer of animal health pharmaceuticals focused on the US market.
DW Healthcare Partners V, L.P. ("DWHP"), announced today the expiration and final results of its previously announced cash tender offer (the "Tender Offer") to purchase all of the outstanding ordinary shares (the "Tender Securities") of Parnell Pharmaceuticals Holdings Ltd (OTC Pink Open Market: PARNF) ("Parnell") at a price of U.S.$0.40 per share, net to the seller in cash without interest and less applicable withholding taxes. The Tender Offer expired at one minute after 11:59 p.m., New York City time on January 28, 2021 (the "Expiration Time").